# FDA 483 - Tulsa Fertility Center, P.C. - July 16, 2025

Source: https://www.keypedia.com/records/483/tulsa-fertility-center-pc/ab0b2a1f-5c39-4270-9a4a-8d9f3300808a

> FDA 483 for Tulsa Fertility Center, P.C. on July 16, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Tulsa Fertility Center, P.C.
- Inspection Date: 2025-07-16
- Product Type: biologics
- Office Name: Dallas District Office
- Summary: An FDA inspection of Tulsa Fertility Center, P.C. in Tulsa, OK, revealed a significant deficiency related to donor screening procedures. The firm failed to establish and maintain proper procedures for screening HCT/P donors, specifically lacking a method for administering the donor history screening questionnaire. This issue impacts numerous anonymous and directed oocyte and semen donors screened by the facility.

## Related Officers

- [Elyshia Q. Danaher](https://www.keypedia.com/people/elyshia-q-danaher/73046c15-abb1-431e-8a76-59c7e8c1604a)

Company: https://www.keypedia.com/companies/tulsa-fertility-center-pc/fa0e9675-a4b6-423c-9e21-bffd22939fe3

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9